Valuation: OrganiGram

Market Cap 192M 137M 122M 112M 102M 12.98B 197M 1.34B 540M 6.85B 514M 503M 21.71B P/E 2026 *
1.69x
P/E 2027 * 17x
Enterprise Value 192M 137M 122M 112M 102M 12.98B 197M 1.34B 540M 6.85B 514M 503M 21.71B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.42x
Free-Float
68.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 14/01/2026
Director of Finance/CFO - 07/01/2024
Chief Operating Officer - 18/08/2026
Director TitleAgeSince
Chairman 65 28/03/2018
Director/Board Member 56 16/12/2018
Director/Board Member 70 16/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 137M
+3.28%-1.21%+16.97%+31.26% 113B
-1.04%-0.52%+0.69%+103.08% 97.71B
+2.56%-4.02%+95.36%+858.40% 54.62B
+3.71%+1.17%-6.04%+82.74% 30.65B
-0.47%+7.28%+39.36%+72.51% 28.87B
-1.50%+1.69%+40.41%+88.12% 27.59B
-0.82%-0.84%+29.15%+394.24% 21.4B
-1.28%-6.70%-22.01%-18.49% 19.74B
-1.15%-1.02%-5.94%+29.77% 17.04B
Average -0.17%-0.29%+20.88%+182.40% 45.65B
Weighted average by Cap. +0.72%-1.27%+22.76%+185.32%

Financials

2026 *2027 *
Net sales 350M 250M 223M 205M 186M 23.67B 359M 2.45B 985M 12.49B 938M 918M 39.6B 458M 327M 292M 269M 244M 31B 470M 3.21B 1.29B 16.36B 1.23B 1.2B 51.86B
Net income 128M 91.67M 81.9M 75.23M 68.32M 8.68B 132M 898M 361M 4.58B 344M 337M 14.53B 8.1M 5.79M 5.17M 4.75M 4.31M 548M 8.3M 56.69M 22.81M 289M 21.72M 21.26M 917M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - OrganiGram